ABBVIE INC. vs. Praxis Precision Medicines, Inc. Common Stock
ABBV
ABBVIE INC.
$266.28 +0.73%
VS PRAXPraxis Precision Medicines, Inc. Common Stock
$334.58 -1.18%
ABBVIE INC. (ABBV) comes out ahead, leading on 5 of 6 compared factors.
Size & Scale
| ABBV | PRAX | |
|---|---|---|
| Market Cap | $467.12 billion | $9.34 billion |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | $-339,126,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | PRAX | |
|---|---|---|
| P/E Ratio | 75.22 | — |
| Price / Book | -79.33 | 6.97 |
| Price / Sales | 7.25 | — |
ABBV leads on 1 of 1 valuation factors.
Profitability
| ABBV | PRAX | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | -25.29% |
PRAX leads on 1 of 1 profitability factors.
Dividend
| ABBV | PRAX | |
|---|---|---|
| Dividend Yield | 2.60% | — |
| Payout Ratio | 195.48 | — |
ABBV and PRAX split the dividend factors evenly.
Risk & Sentiment
| ABBV | PRAX | |
|---|---|---|
| Short Interest | 0.85% | 1.95% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, PRAX overview, PRAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.